Terms: = Prostate cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Treatment
31 results:
1. Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents: A review.
Gomes AR; Varela CL; Pires AS; Tavares-da-Silva EJ; Roleira FMF
Bioorg Chem; 2023 Sep; 138():106600. PubMed ID: 37209561
[TBL] [Abstract] [Full Text] [Related]
2. Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.
Sonawane V; Ghosalkar J; Achrekar S; Joshi K
Sci Rep; 2023 Apr; 13(1):5659. PubMed ID: 37024613
[TBL] [Abstract] [Full Text] [Related]
3. TRPM8 as an Anti-Tumoral Target in prostate cancer Growth and Metastasis Dissemination.
Grolez GP; Chinigò G; Barras A; Hammadi M; Noyer L; Kondratska K; Bulk E; Oullier T; Marionneau-Lambot S; Le Mée M; Rétif S; Lerondel S; Bongiovanni A; Genova T; Roger S; Boukherroub R; Schwab A; Fiorio Pla A; Gkika D
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743115
[TBL] [Abstract] [Full Text] [Related]
4. Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy.
Weidhaas J; Marco N; Scheffler AW; Kalbasi A; Wilenius K; Rietdorf E; Gill J; Heilig M; Desler C; Chin RK; Kaprealian T; McCloskey S; Raldow A; Raja NP; Kesari S; Carrillo J; Drakaki A; Scholz M; Telesca D
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35115362
[TBL] [Abstract] [Full Text] [Related]
5. Hormone-Dependent prostate cancers are Dependent on Rac Signaling for Growth and Survival.
Goka ET; Mesa Lopez DT; Lippman ME
Mol Cancer Ther; 2021 Jun; 20(6):1052-1061. PubMed ID: 33722851
[TBL] [Abstract] [Full Text] [Related]
6. Identifying and treating ROBO1
Ferrari MG; Ganaie AA; Shabenah A; Mansini AP; Wang L; Murugan P; Davicioni E; Wang J; Deng Y; Hoeppner LH; Warlick CA; Konety BR; Saleem M
Prostate; 2020 Sep; 80(13):1045-1057. PubMed ID: 32687658
[TBL] [Abstract] [Full Text] [Related]
7. POTEE promotes colorectal carcinoma progression via activating the rac1/Cdc42 pathway.
Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
[TBL] [Abstract] [Full Text] [Related]
8. Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models.
Weissenrieder JS; Reilly JE; Neighbors JD; Hohl RJ
Prostate; 2019 Jan; 79(1):21-30. PubMed ID: 30106164
[TBL] [Abstract] [Full Text] [Related]
9. p66Shc regulates migration of castration-resistant prostate cancer cells.
Ingersoll MA; Chou YW; Lin JS; Yuan TC; Miller DR; Xie Y; Tu Y; Oberley-Deegan RE; Batra SK; Lin MF
Cell Signal; 2018 Jun; 46():1-14. PubMed ID: 29462661
[TBL] [Abstract] [Full Text] [Related]
10. Targeting epithelial to mesenchymal transition in prostate cancer by a novel compound, plectranthoic acid, isolated from Ficus microcarpa.
Akhtar N; Syed DN; Lall RK; Mirza B; Mukhtar H
Mol Carcinog; 2018 May; 57(5):653-663. PubMed ID: 29436741
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.
Herlemann A; Keller P; Schott M; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Yu Q; Waidelich R; Strittmatter F; Stief CG; Gratzke C; Hennenberg M
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F47-F57. PubMed ID: 28855187
[TBL] [Abstract] [Full Text] [Related]
12. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract] [Full Text] [Related]
13. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract] [Full Text] [Related]
14. Snail promotes cell migration through PI3K/AKT-dependent rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract] [Full Text] [Related]
15. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract] [Full Text] [Related]
16. Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform.
Webber J; Stone TC; Katilius E; Smith BC; Gordon B; Mason MD; Tabi Z; Brewis IA; Clayton A
Mol Cell Proteomics; 2014 Apr; 13(4):1050-64. PubMed ID: 24505114
[TBL] [Abstract] [Full Text] [Related]
17. A rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract] [Full Text] [Related]
18. Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of prostate-Specific Membrane Antigen.
Schmidt S; Gericke B; Fracasso G; Ramarli D; Colombatti M; Naim HY
PLoS One; 2013; 8(6):e66193. PubMed ID: 23840421
[TBL] [Abstract] [Full Text] [Related]
19. Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration.
McAuley EM; Bradke TA; Plopper GE
Cell Adh Migr; 2011; 5(5):382-6. PubMed ID: 21975546
[TBL] [Abstract] [Full Text] [Related]
20. 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.
Pang X; Zhang L; Lai L; Chen J; Wu Y; Yi Z; Zhang J; Qu W; Aggarwal BB; Liu M
Carcinogenesis; 2011 Jun; 32(6):904-12. PubMed ID: 21427164
[TBL] [Abstract] [Full Text] [Related]
[Next]
